Insurance coverage of wearables is spotty. This could soon change as Medicare begins a pilot to facilitate access to ...

The government is right to focus on fraud, waste and abuse. But its oversight efforts should be targeted, data-driven and ...

The Office of Health Technology and Products is the latest technology development from the CMS as it doubles down on digital ...

The Centers for Medicare & Medicaid Services has established a new Office of Health Technology and Products to oversee healthcare technology modernization, digital products and platform transformation ...

Alongside their annual criticisms of the Centers for Medicare and Medicaid Services’ annual pay rate increase for inpatient ...

"We continue to make progress against our top priorities of maintaining strong margins, reducing our cost structure and moving the business towards sustainable profitability," said CEO, Secretary & ...

Jeneen Iwugo, right, acting director of CMS's Center for Program Integrity, and Sarah Harvey, left, director of the GAO's Science & Technology Assessment division, participate in a panel discussion at ...

A financially sustainable solution for how to cover GLP-1 drugs for obesity remains elusive. The Centers for Medicare & Medicaid Services (CMS) has announced that its temporary program to cover GLP-1 ...

CHARLOTTE — Charlotte‑Mecklenburg Schools is considering major changes to its magnet programs, including a proposal to merge two of the district’s most rigorous academic pathways. CMS leaders will ...

The proposed rule on interoperability standards and prior authorization could lead to significant change in CMS. Prior authorization has become one of the clearest points where administrative ...

Health and Human Services Secretary Robert F. Kennedy Jr. sparked outrage among disability rights advocates with recent comments alleging widespread fraud in Medicaid programs that pay people to care ...

Medicare has delayed a program for older Americans that would've required participating insurance companies to cover GLP-1 weight loss drugs such as Novo Nordisk's Wegovy and Eli Lilly's Zepbound.